These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23093258)
1. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options. Papantoniou N; Sifakis S; Antsaklis A J Perinat Med; 2013 Jan; 41(1):71-82. PubMed ID: 23093258 [TBL] [Abstract][Full Text] [Related]
3. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion. Lakhwani S; Machado P; Pecos P; Coloma M; Rebollo S; Raya JM Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196 [TBL] [Abstract][Full Text] [Related]
4. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis. Somerset DA; Moore A; Whittle MJ; Martin W; Kilby MD Fetal Diagn Ther; 2006; 21(3):272-6. PubMed ID: 16601337 [TBL] [Abstract][Full Text] [Related]
5. Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study. Deka D; Sharma KA; Dadhwal V; Singh A; Kumar G; Vanamail P Fetal Diagn Ther; 2013; 34(3):146-51. PubMed ID: 23941890 [TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy. Novak DJ; Tyler LN; Reddy RL; Barsoom MJ J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884 [TBL] [Abstract][Full Text] [Related]
8. Intrauterine blood transfusion: current indications and associated risks. Lindenburg IT; van Kamp IL; Oepkes D Fetal Diagn Ther; 2014; 36(4):263-71. PubMed ID: 24903741 [TBL] [Abstract][Full Text] [Related]
9. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076 [TBL] [Abstract][Full Text] [Related]
10. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report. Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100 [TBL] [Abstract][Full Text] [Related]
11. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome. Zwiers C; van Kamp I; Oepkes D; Lopriore E Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805 [TBL] [Abstract][Full Text] [Related]
12. The effect of fetal anemia on fetal cardiac troponin T in pregnancies complicated by RhD alloimmunization. Nomura RM; Brizot Mde L; Liao AW; Nishie EN; Zugaib M J Matern Fetal Neonatal Med; 2013 Feb; 26(3):246-9. PubMed ID: 23013237 [TBL] [Abstract][Full Text] [Related]
13. [Analysis and perinatal outcome after intravascular transfusion]. Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826 [TBL] [Abstract][Full Text] [Related]
14. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization. Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382 [TBL] [Abstract][Full Text] [Related]
15. Early intrauterine transfusion in severe red blood cell alloimmunization. Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139 [TBL] [Abstract][Full Text] [Related]
16. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation. Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132 [TBL] [Abstract][Full Text] [Related]
17. Relationship between obstetric history and Rh(D) alloimmunization severity. Lobato G; Soncini CS Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861 [TBL] [Abstract][Full Text] [Related]
18. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008]. Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunization. Deka D; Buckshee K; Kinra G J Obstet Gynaecol Res; 1996 Dec; 22(6):561-7. PubMed ID: 9037945 [TBL] [Abstract][Full Text] [Related]
20. Perinatal outcomes and survival predictors of severe red-cell alloimmunization treated by intrauterine transfusion. Arslan E; Demir SC; Ozsurmeli M; Akcabay C J Obstet Gynaecol Res; 2021 Aug; 47(8):2632-2640. PubMed ID: 34018269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]